Omed Tablet 10 mg (Omeprazole)

Adult dose

Administer 20 mg orally once daily. Treatment duration varies from 2 to 8 weeks depending on symptoms, and dose increase or extension of treatment duration is possible if necessary. In specific cases (Zollinger-Ellison syndrome), administer 60 mg orally once daily, and if more than 80 mg is administered, divide into two doses daily. In antibiotic combination therapy, administer 20 mg or 40 mg once or twice daily. NSAID related ulcers.

This medication should not be administered to certain patients. For example, patients allergic to any component of this medication or those with a malignant tumor possibility in gastric ulcers should not use this medication, as it may mask symptoms, leading to delayed diagnosis in cancer patients. Additionally, concomitant administration with medications containing Atazanavir or Lopinavir is prohibited. Patients with impaired hepatic function or the elderly should be cautious when using this medication. Dosage should be limited for patients with severely impaired liver function. Several side effects may occur while taking this medication. Common neurological symptoms such as headache, drowsiness, dizziness may occur, and liver enzyme levels may elevate due to liver dysfunction. Gastrointestinal symptoms such as diarrhea, constipation, nausea, abdominal pain may appear, and skin rash or itching, and in severe cases, serious skin reactions such as Stevens-Johnson syndrome may occur. Rarely, various adverse reactions such as blood disorders, muscle pain, gynecomastia, and hypomagnesemia have been reported. Long-term use of this medication may mask symptoms of malignant tumors such as gastric cancer; thus, examinations are necessary if weight loss, recurrent vomiting, or hematemesis occur. Regular testing is recommended for long-term use exceeding one year, and caution should be exercised as the risk of fractures may increase. Hypomagnesemia may occur, requiring periodic checks of magnesium levels, and supplementation therapy may be necessary when needed. This medication may interact with other drugs; therefore, be sure to inform your healthcare provider of any other medications you are taking. Special caution is needed when used with warfarin, diazepam, cyclosporine, methotrexate, etc. Co-administration with Atazanavir is prohibited. Women who are pregnant or may become pregnant should carefully weigh the risks and benefits when using this medication, and it is advisable that breastfeeding women either avoid this medication or discontinue breastfeeding. Safety in children has not been established. In cases of overdose, symptoms such as vomiting, diarrhea, headache, confusion can occur, but they are generally temporary, and severe consequences are rarely reported. This medication must be kept out of the reach of children and should not be transferred to another container; the cap of the container should be tightly closed after use.

Serious side effects

• Hives
• severe swelling (angioedema)
• tightness in the chest
• difficulty breathing
• cold sweat
• pale skin
• serious allergic reaction
• severe rash with high fever
• blisters
• skin peeling

Mild side effects

• Headache
• drowsiness
• dizziness
• insomnia
• paresthesia
• fainting feeling
• confusion
• agitation
• aggression
• hallucinations

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius (room temperature). Proper storage will help maintain the medication's effectiveness and safety over time.

Appearance

Round enteric-coated tablets in pale gray color

Package unit

30 tablets/bottle, 500 tablets/bottle